Effective August 29, 2024, ARCA biopharma is Oruka Therapeutics. Please refer to this press release (https://finance.yahoo.com/news/arca-biopharma-announces-completion-merger-205000475.html) regarding the completion of the merger with Oruka Therapeutics, Inc. Please visit Oruka Therapeutics at www.orukatx.com.
Effective August 29, 2024, ARCA biopharma is Oruka Therapeutics. Please refer to this press release (https://finance.yahoo.com/news/arca-biopharma-announces-completion-merger-205000475.html) regarding the completion of the merger with Oruka Therapeutics, Inc. Please visit Oruka Therapeutics at www.orukatx.com.
Mr. Keuer has served as the Company’s Chief Operating Officer since December 2014. Mr. Keuer served as the Company’s Executive Vice...[+more]
Mr. Dekker has served as the Company’s Chief Financial Officer since May 2021. Prior to joining the Company, Mr. Dekker...[+more]
Mr. Conway was appointed to the Board of Directors in September 2013, and has served as the Chairman of our...[+more]
Dr. Grais has served as a member of the Board of Directors since May 2007. Dr. Grais was a director...[+more]
Dr. Hove has served as a member of the Board of Directors since February 2017. Dr. Hove is the manager...[+more]
Mr. Ma-Weaver was appointed to the Board of Directors in June 2022. Mr. Ma-Weaver is the Managing Member of Cable...[+more]
Mr. Flynn has served as a member of the Board of Directors since December 2022. Mr. Flynn is currently a...[+more]